DK0724646T3 - DNA sekvenser knyttet til isoleret fragilt X syndrom - Google Patents

DNA sekvenser knyttet til isoleret fragilt X syndrom

Info

Publication number
DK0724646T3
DK0724646T3 DK92904375T DK92904375T DK0724646T3 DK 0724646 T3 DK0724646 T3 DK 0724646T3 DK 92904375 T DK92904375 T DK 92904375T DK 92904375 T DK92904375 T DK 92904375T DK 0724646 T3 DK0724646 T3 DK 0724646T3
Authority
DK
Denmark
Prior art keywords
fragile
isolated
syndrome
dna sequences
sequences associated
Prior art date
Application number
DK92904375T
Other languages
Danish (da)
English (en)
Inventor
Grant R Sutherland
Robert I Richards
David Schlessinger
Ramaiah Nagaraja
Original Assignee
Univ Washington
Adelaide Medical Ct For Women
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27417620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0724646(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Washington, Adelaide Medical Ct For Women filed Critical Univ Washington
Application granted granted Critical
Publication of DK0724646T3 publication Critical patent/DK0724646T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Error Detection And Correction (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK92904375T 1991-01-04 1992-01-03 DNA sekvenser knyttet til isoleret fragilt X syndrom DK0724646T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63851891A 1991-01-04 1991-01-04
US67223291A 1991-03-20 1991-03-20
US80265091A 1991-12-06 1991-12-06
PCT/US1992/000020 WO1992012262A1 (en) 1991-01-04 1992-01-03 Dna sequences related to isolated fragile x syndrome

Publications (1)

Publication Number Publication Date
DK0724646T3 true DK0724646T3 (da) 2001-09-03

Family

ID=27417620

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92904375T DK0724646T3 (da) 1991-01-04 1992-01-03 DNA sekvenser knyttet til isoleret fragilt X syndrom

Country Status (11)

Country Link
US (2) US6197500B1 (de)
EP (1) EP0724646B1 (de)
JP (1) JPH06504443A (de)
AT (1) ATE202599T1 (de)
AU (1) AU668857B2 (de)
CA (1) CA2094938A1 (de)
DE (1) DE69231903T2 (de)
DK (1) DK0724646T3 (de)
ES (1) ES2159279T3 (de)
GR (1) GR3036691T3 (de)
WO (1) WO1992012262A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672618B1 (fr) * 1991-02-13 1994-12-02 Centre Nat Rech Scient Fragment d'acide nucleique de la region du chromosome x implique dans le syndrome x fragile, sonde nucleotidique et procede pour le diagnostic du retard mental avec x fragile.
US5378602A (en) * 1991-05-29 1995-01-03 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Highly informative microsatellite repeat polymorphic DNA markers twenty-[seven]six
US5861504A (en) * 1991-05-29 1999-01-19 The United States Of America As Represented By The Department Of Health And Human Services Eleven highly informative microsatelite repeat polymorphic DNA markers
GB9311113D0 (en) * 1993-05-28 1993-07-14 Medical Res Council Probes
US5741645A (en) * 1993-06-29 1998-04-21 Regents Of The University Of Minnesota Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
US5834183A (en) * 1993-06-29 1998-11-10 Regents Of The University Of Minnesota Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
GB9326052D0 (en) * 1993-12-21 1994-02-23 Zeneca Ltd Sequences
US5876949A (en) * 1995-05-31 1999-03-02 The Trustees Of The University Of Pennsylvania Antibodies specific for fragile X related proteins and method of using the same
GB9519299D0 (en) 1995-09-21 1995-11-22 Farrar Gwyneth J Genetic strategy
GB9604449D0 (en) * 1996-03-01 1996-05-01 Farrar Gwyneth J Genetic strategy ii
GB9606961D0 (en) 1996-04-02 1996-06-05 Farrar Gwyneth J Genetic strategy III
US8551970B2 (en) 1996-04-02 2013-10-08 Optigen Patents Limited Genetic suppression and replacement
AU1233900A (en) * 1998-10-27 2000-05-15 Johns Hopkins University, The Ccg repeats in cdnas from human brain
AUPR909501A0 (en) 2001-11-26 2001-12-20 Bionomics Limited A novel homeobox gene
US7115374B2 (en) * 2002-10-16 2006-10-03 Gen-Probe Incorporated Compositions and methods for detecting West Nile virus
US7927840B2 (en) * 2006-09-11 2011-04-19 Gen Probe Incorporated Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
US20050191636A1 (en) * 2004-03-01 2005-09-01 Biocept, Inc. Detection of STRP, such as fragile X syndrome
CA2649777C (en) * 2006-04-17 2018-08-14 Epigenomics Ag Methods and nucleic acids for the detection of colorectal cell proliferative disorders
BR112013010585B1 (pt) * 2010-10-29 2020-12-01 Asuragen, Inc. método de caracterização de um locus de fmr1 ou um locus de frm2 em uma amostra de dna e método de análise de um locus fmr1 ou um locus fmr2 de uma amostra de dna humana

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2578847A1 (fr) 1985-03-13 1986-09-19 Centre Nat Rech Scient Sonde adn destinee au diagnostic antenatal de certaines anomalies chromosomiques
GB8825530D0 (en) * 1988-11-01 1988-12-07 Medical Res Council Probe
GB8928029D0 (en) * 1989-12-12 1990-02-14 Medical Res Council Probe
WO1992014840A1 (fr) 1991-02-13 1992-09-03 Institut National De La Sante Et De La Recherche Medicale Fragment d'acide nucleique de la region du chromosome x implique dans le syndrome x fragile, sonde nucleotidique et procede pour le diagnostic du retard mental avec x fragile
US6180337B1 (en) * 1991-05-24 2001-01-30 Baylor College Of Medicine Diagnosis of the fragile X syndrome

Also Published As

Publication number Publication date
US6197500B1 (en) 2001-03-06
ES2159279T3 (es) 2001-10-01
GR3036691T3 (en) 2001-12-31
DE69231903T2 (de) 2001-10-31
CA2094938A1 (en) 1992-07-05
JPH06504443A (ja) 1994-05-26
ATE202599T1 (de) 2001-07-15
EP0724646B1 (de) 2001-06-27
DE69231903D1 (de) 2001-08-02
AU1221192A (en) 1992-08-17
US6242576B1 (en) 2001-06-05
EP0724646A4 (de) 1995-06-09
AU668857B2 (en) 1996-05-23
WO1992012262A1 (en) 1992-07-23
EP0724646A1 (de) 1996-08-07

Similar Documents

Publication Publication Date Title
DK0724646T3 (da) DNA sekvenser knyttet til isoleret fragilt X syndrom
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
NL300066I2 (nl) Behandeling van zwaarlijvigheid.
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
LV10878A (lv) Adas apstradasana ar izveletiem amfifiliem kopolimeriem
DE59310327D1 (de) Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura
FI925549A0 (fi) Nya azaheterocyklylmetyl-kromaner
DE69203990D1 (de) Einrichtung zur transdermalen Verabreichung von Medikamenten.
DE69427848D1 (de) Unterstützungssystem zur Herstellung von Wörterbüchern
DE3781005D1 (de) Adsorptionsmittel fuer chromatographie, methode zur herstellung desselben und saeulensystem fuer chromatographie.
EP0723460A4 (de) Gentherapie für das nervensystems
NO873699D0 (no) Polypeptid som er egnet til dempning, behandling og diagnosering av autoimmune lidelser saasom leddbetennelser.
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
DE69209273D1 (de) Permselektive polyacrylnitrilcopolymermembran und ihre herstellung
DE59401899D1 (de) Längenverstellbare Säule für Stühle, Tische o.dgl.
DK0825857T3 (da) Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse
HUP9802423A2 (hu) Hiperproliferatív megbetegedések kombinált gyógyászati kezelése
FR2704773B1 (fr) Procédé de préparation de catalyseurs utilisables en déshydrogénation.
HUP9801681A2 (hu) Mutáns proteinek
DE69734461D1 (de) Verwendung von mycobacterium vaccae zur therapie des chronischen müdigkeitssyndrom
DK89489D0 (da) Anvendelse af halogenerede allylaminer til fremstilling af et farmaceutisk praeparat
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
DE59008586D1 (de) Zweistufen-Verfahren zur Herstellung von Polycarbonaten auf Basis von speziellen Dihydroxydiphenylalkanen.
DK0842193T3 (da) Somatostatin-analoge cykliske peptider med hæmmende aktivitet på væksthormon
NO894220D0 (no) Innretning for gjennomfoering av membranadskillelsesprosesser.